isotonic_sheet
TL3 Regular · Brno, CZ
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 31 December 2024 · last posted 7d · groups: analytical-chemists
144 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #56 · Access › Shortages · 21 Jul 2026 · 16 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Splitting an overlong document into two Replied, post #33 · Documentation › Wiki requests · 18 Jul 2026 · 3 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Journal club: what we got wrong in an earlier session Replied, post #85 · Evidence › Journal club · 15 Jul 2026 · 14 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Why chargeback is not the safety net people assume Replied, post #24 · Sourcing › Payments · 11 Jul 2026 · 7 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #32 · Start Here › Welcome · 3 Jul 2026 · 11 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
How shortages have affected compounding permissions Replied, post #12 · Access › Shortages · 3 Jul 2026 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Prescription requirements and telehealth models — a second dataset Replied, post #87 · Sourcing › Regulatory · 1 Jul 2026 · 22 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Submitting a sample: the process end to end Replied, post #39 · Sourcing › Independent verification · 26 Jun 2026 · 4 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #44 · Compounds › Repair & healing peptides · 18 Jun 2026 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Racemisation and why it is invisible to a mass measurement Replied, post #36 · Analytics › Impurities & related substances · 10 Jun 2026 · 17 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Naming conventions for research peptides and the confusion they cause Replied, post #13 · Compounds › Other compounds · 9 Jun 2026 · 3 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Reading a trial's population section before its results Replied, post #87 · Evidence › Trials · 4 Jun 2026 · 0 likes post #86 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #22 · Compounds › Secretagogues & GH axis · 3 Jun 2026 · 8 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Historical amylin analogues and what happened to them Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 29 May 2026 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Tracking intake honestly when appetite is absent Replied, post #39 · Nutrition & Training › Protein & intake · 28 May 2026 · 5 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Spreadsheets: an appreciation — what changed since Replied, post #48 · Lounge › Off topic · 21 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
An 18-month record including the parts that went badly Replied, post #20 · Outcomes › Progress reports · 20 May 2026 · 1 like Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #25 · Evidence › Trials · 12 May 2026 · 21 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #39 · Compounds › Tirzepatide · 10 May 2026 · 11 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #21 · Pharmacology › Formulation chemistry · 7 May 2026 · 0 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Blind submission and why it changes minds — the long version Replied, post #57 · Sourcing › Independent verification · 5 May 2026 · 26 likes On post #53 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #8 · Analytics › COA interpretation · 28 Apr 2026 · 11 likes This follows post #5 rather than contradicting it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #32 · Practice › Interactions · 25 Apr 2026 · 6 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #25 · Clinical › Bloodwork · 24 Apr 2026 · 0 likes post #24 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Coming back to: Time to steady state after a dose increase Replied, post #37 · Pharmacology › Pharmacokinetics · 21 Apr 2026 · 1 like post #36 answers the question as asked. The question underneath it is different. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…
-
Micro-titration: a disputed topic, argued properly Replied, post #62 · Practice › Dosing & titration · 19 Apr 2026 · 2 likes post #61 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #15 · Devices › Syringes & needles · 14 Apr 2026 · 7 likes This follows post #12 rather than contradicting it. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood)…
-
Choosing which test to pay for, given a fixed budget Replied, post #65 · Sourcing › Independent verification · 11 Apr 2026 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #44 · Practice › Interactions · 9 Apr 2026 · 3 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #55 · Data & Tools › Calculators · 29 Mar 2026 · 22 likes Worth separating two things that post #51 runs together. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They…
-
Grapefruit: why this class is not the class that cares Replied, post #89 · Practice › Interactions · 28 Mar 2026 · 27 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #20 · Meta › Announcements · 23 Mar 2026 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Questions welcomed: if an announcement is unclear, asking for clarification is welcome.…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #17 · Analytics › Impurities & related substances · 17 Mar 2026 · 0 likes post #16 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #51 · Start Here › Welcome · 9 Mar 2026 · 15 likes post #50 answers the question as asked. The question underneath it is different. Welcome. The orientation materials are pinned at the top of this category and they take…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #14 · Compounds › Repair & healing peptides · 8 Mar 2026 · 9 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #149 · Sourcing › Independent verification · 5 Mar 2026 · 31 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #99 · Evidence › Study critique · 1 Mar 2026 · 1 like post #98 is right about the mechanism and I think understates the practical bit. Generalisability: do the inclusion/exclusion criteria narrow the population so much…
-
A single out-of-range value on an otherwise normal panel Replied, post #18 · Clinical › Bloodwork · 27 Feb 2026 · 5 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Choosing which test to pay for, given a fixed budget Replied, post #6 · Sourcing › Independent verification · 25 Feb 2026 · 4 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Measurement error in a self-reported exposure Replied, post #67 · Evidence › Study critique · 25 Feb 2026 · 17 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 20 Feb 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #80 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #13 · Compounds › Secretagogues & GH axis · 11 Feb 2026 · 0 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #21 · Compounds › Semaglutide · 6 Feb 2026 · 32 likes I read post #19 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
-
Dead volume across syringe and needle combinations Replied, post #65 · Devices › Syringes & needles · 2 Feb 2026 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #31 · Practice › Storage & stability · 2 Feb 2026 · 2 likes I read post #29 twice before replying, because I had assumed the opposite. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
Revisiting: Absolute versus relative contraindications Replied, post #16 · Safety › Contraindications · 30 Jan 2026 · 33 likes Coming back to post #14, because the follow-up matters more than the original answer. Medullary thyroid carcinoma (personal or family history) or multiple endocrine…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #13 · Clinical › Comorbidities · 22 Jan 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What a stability-indicating method is and how you demonstrate one Replied, post #4 · Analytics › Method validation · 19 Jan 2026 · 13 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
MHRA statements, read directly Replied, post #70 · Regional › UK & Ireland · 17 Jan 2026 · 9 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Adolescents: a distinct evidence base — one year on Replied, post #54 · Clinical › Special populations · 15 Jan 2026 · 13 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #7 · Outcomes › Body composition · 12 Jan 2026 · 6 likes Picking up post #4: that is the part I would want checked first. Precision versus accuracy: the precision you need depends on what question you are answering. "Am I…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #49 · Pharmacology › Pharmacokinetics · 31 Dec 2025 · 27 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Early satiety becoming a problem rather than a benefit Replied, post #20 · Practice › Side effects · 29 Dec 2025 · 1 like I read post #18 twice before replying, because I had assumed the opposite. Nausea: the most common side effect and the most dose- and titration-dependent one. It is…
-
Tracking that stops updating and then resumes Replied, post #61 · Sourcing › Logistics · 28 Dec 2025 · 0 likes post #60 answers the question as asked. The question underneath it is different. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there…
-
Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #4 · Compounds › Tirzepatide · 12 Dec 2025 · 13 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Tracking that stops updating and then resumes — the long version Replied, post #43 · Sourcing › Logistics · 26 Nov 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #55 · Compounds › Semaglutide · 26 Nov 2025 · 7 likes Picking up post #52: that is the part I would want checked first. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #19 · Compounds › Oral incretins · 25 Nov 2025 · 1 like This follows post #16 rather than contradicting it. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a…
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #4 · Practice › Storage & stability · 24 Nov 2025 · 10 likes This follows post #3 rather than contradicting it. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods…
-
Thyroid function tests during substantial weight change Replied, post #147 · Clinical › Bloodwork · 24 Nov 2025 · 0 likes I read post #145 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Pen dose counters: what a click does and does not guarantee Replied, post #95 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes On post #91 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] What steady state means for the decision to escalate Replied, post #87 · Practice › Dosing & titration · 14 Nov 2025 · 6 likes I read post #85 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
About the Prescriber conversations category Replied, post #12 · Clinical › Prescriber conversations · 26 Oct 2025 · 2 likes This follows post #9 rather than contradicting it. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan.…
-
New subcategory: rationale and scope Replied, post #119 · Meta › Announcements · 25 Oct 2025 · 21 likes post #118 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #42 · Compounds › Tirzepatide · 20 Oct 2025 · 9 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #120 · Practice › Administration · 20 Oct 2025 · 10 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #91 · Devices › Cold chain · 17 Oct 2025 · 27 likes post #90 is right about the mechanism and I think understates the practical bit. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque…
-
A preprint whose numbers changed substantially at publication Replied, post #55 · Evidence › Preprints · 16 Sep 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #50 · Analytics › Method validation · 14 Sep 2025 · 9 likes Worth separating two things that post #46 runs together. Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay…
-
Temperature loggers worth the money Replied, post #29 · Devices › Cold chain · 12 Sep 2025 · 0 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #96 · Data & Tools › Datasets · 10 Sep 2025 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #75 · Data & Tools › Datasets · 9 Sep 2025 · 33 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #18 · Practice › Reconstitution · 1 Sep 2025 · 2 likes post #17 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #59 · Evidence › Journal club · 30 Aug 2025 · 10 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
EU-wide position versus national implementation Replied, post #28 · Regional › European Union · 24 Aug 2025 · 26 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #42 · Compounds › Retatrutide · 10 Aug 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #10 · Evidence › Journal club · 10 Aug 2025 · 1 like FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
An emergency department visit, described afterwards Replied, post #52 · Safety › Adverse events · 10 Aug 2025 · 0 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
A request that was declined, and the reasoning — a second dataset Replied, post #4 · Documentation › Wiki requests · 4 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How to research a compound with no human data without deceiving yourself Replied, post #98 · Compounds › Other compounds · 4 Aug 2025 · 3 likes This follows post #95 rather than contradicting it. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested…
-
How to research a compound with no human data without deceiving yourself Replied, post #87 · Compounds › Other compounds · 3 Aug 2025 · 0 likes post #86 is right about the mechanism and I think understates the practical bit. Compounds this community declines to help with, and why: there are specifics in the…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #63 · Sourcing › Regulatory · 29 Jul 2025 · 4 likes This follows post #60 rather than contradicting it. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #40 · Devices › Syringes & needles · 27 Jul 2025 · 7 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 15 Jul 2025 · 2 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
System suitability injections: if they failed, the run did not happen Replied, post #14 · Analytics › HPLC & UHPLC · 13 Jul 2025 · 20 likes post #13 is right about the mechanism and I think understates the practical bit. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #88 · Wellbeing › Mental health · 12 Jul 2025 · 0 likes On post #84 — agreed on the reasoning, with one qualification. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 10 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #23 · Practice › Reconstitution · 10 Jul 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #153 · Evidence › Journal club · 7 Jul 2025 · 20 likes On post #149 — agreed on the reasoning, with one qualification. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #82 · Compounds › Tirzepatide · 4 Jul 2025 · 0 likes post #81 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #31 · Analytics › Mass spectrometry · 4 Jul 2025 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #47 · Compounds › Repair & healing peptides · 22 Jun 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #89 · Practice › Reconstitution · 22 Jun 2025 · 0 likes I read post #87 twice before replying, because I had assumed the opposite. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #46 · Regional › UK & Ireland · 17 Jun 2025 · 0 likes This follows post #43 rather than contradicting it. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #10 · Compounds › Repair & healing peptides · 17 Jun 2025 · 13 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
EU-wide position versus national implementation Replied, post #11 · Regional › European Union · 15 Jun 2025 · 13 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #26 · Analytics › Mass spectrometry · 11 Jun 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #25 · Analytics › Home & field testing · 10 Jun 2025 · 0 likes This follows post #22 rather than contradicting it. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes…
-
Washout: how long is long enough, and for what purpose Replied, post #30 · Pharmacology › Pharmacokinetics · 28 May 2025 · 6 likes Picking up post #27: that is the part I would want checked first. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete…
-
Half-life, steady state, and accumulation worked through Replied, post #26 · Pharmacology › Pharmacokinetics · 26 May 2025 · 21 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #37 · Compounds › Oral incretins · 25 May 2025 · 1 like Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #20 · Research Methods › N-of-1 designs · 19 May 2025 · 2 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
About the Body composition category Replied, post #6 · Outcomes › Body composition · 7 May 2025 · 26 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Antibiotics and a course of something with delayed emptying Replied, post #34 · Practice › Interactions · 4 May 2025 · 3 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Adjudicated events and why the definition matters — the long version Replied, post #119 · Evidence › Trials · 26 Apr 2025 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Reading an MS report that only gives you a single number Replied, post #58 · Analytics › Mass spectrometry · 21 Apr 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
A supplier that answers analytical questions with restated claims Replied, post #61 · Sourcing › Red flags · 20 Apr 2025 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Requesting a page: what makes a good request Replied, post #52 · Documentation › Wiki requests · 10 Apr 2025 · 32 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
A certificate with no method stated: what can you conclude? Replied, post #44 · Analytics › COA interpretation · 8 Apr 2025 · 17 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #5 · Evidence › Journal club · 17 Mar 2025 · 0 likes This follows post #2 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
Maintainer handover: how it works Replied, post #53 · Meta › Wiki maintenance · 17 Mar 2025 · 32 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #107 · Pharmacology › Receptor biology · 16 Mar 2025 · 3 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Assessing a warm arrival: the decision process Replied, post #14 · Sourcing › Logistics · 15 Mar 2025 · 1 like post #13 answers the question as asked. The question underneath it is different. Customs outcomes are not predictable at the level of an individual parcel. What is…
-
Follow-up: What other technical communities get right that we do not Replied, post #39 · Lounge › Off topic · 14 Mar 2025 · 1 like This follows post #36 rather than contradicting it. Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #6 · Sourcing › Red flags · 9 Mar 2025 · 11 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #138 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
A promotion I argued against, and why I lost Replied, post #109 · Documentation › Doc review · 24 Feb 2025 · 0 likes Worth separating two things that post #105 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Validating a method you did not develop — does this still hold? Replied, post #28 · Analytics › Method validation · 20 Feb 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Reading an MS report that only gives you a single number Replied, post #14 · Analytics › Mass spectrometry · 20 Feb 2025 · 19 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #6 · Clinical › Bloodwork · 18 Feb 2025 · 17 likes post #5 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy person…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #23 · Practice › Interactions · 13 Feb 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What we do not know about retatrutide, listed explicitly Replied, post #88 · Compounds › Retatrutide · 8 Feb 2025 · 13 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Protein density versus volume when you cannot eat much Replied, post #42 · Nutrition & Training › Protein & intake · 30 Jan 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #91 · Compounds › Semaglutide · 24 Jan 2025 · 10 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
A page that has drifted out of date and needs a maintainer Replied, post #43 · Documentation › Wiki requests · 24 Dec 2024 · 3 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #15 · Practice › Interactions · 17 Dec 2024 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #13 · Practice › Dosing & titration · 3 Dec 2024 · 23 likes post #12 is right about the mechanism and I think understates the practical bit. Steady state means the plasma concentration is stable from dose to dose. That happens…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #64 · Compounds › Tirzepatide · 25 Nov 2024 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Fixed versus detachable needles: the trade-offs Replied, post #16 · Devices › Syringes & needles · 23 Nov 2024 · 5 likes Picking up post #13: that is the part I would want checked first. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #30 · Sourcing › Regulatory · 16 Nov 2024 · 6 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #52 · Compounds › Repair & healing peptides · 14 Nov 2024 · 6 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Time to steady state after a dose increase Replied, post #133 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 1 like Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Gallbladder disease risk with rapid weight loss Replied, post #11 · Clinical › Comorbidities · 20 Sep 2024 · 7 likes Coming back to post #9, because the follow-up matters more than the original answer. Cardiovascular disease: several compounds have cardiovascular outcome trials.…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #14 · Clinical › Bloodwork · 7 Sep 2024 · 3 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Correlation in a self-tracked dataset: what it can support Replied, post #56 · Research Methods › Statistics · 22 Aug 2024 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. Absence of evidence and evidence of absence: if a study is small and finds no effect, that is…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #20 · Analytics › COA interpretation · 9 Aug 2024 · 5 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #11 · Analytics › Method validation · 4 Aug 2024 · 2 likes post #10 answers the question as asked. The question underneath it is different. Why two laboratories may disagree: after validating the same method, they may still…
-
[2026 update] Request: show the solution author in the topic list Replied, post #3 · Meta › Feature requests · 1 Aug 2024 · 18 likes I read the opening post twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post…
-
Cold packs, phase-change material, and what survives ten days Replied, post #129 · Sourcing › Logistics · 21 Jul 2024 · 19 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 19 Jul 2024 · 25 likes On post #5 — agreed on the reasoning, with one qualification. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at…
-
How this community labels and discusses unrefereed work Replied, post #97 · Evidence › Preprints · 19 Jul 2024 · 4 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #4 · Compounds › Retatrutide · 15 Jul 2024 · 0 likes the opening post answers the question as asked. The question underneath it is different. The phase 2 obesity paper reported dose-dependent weight reduction of a…